These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36814994)

  • 21. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
    Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].
    Yang Y; Guo SX; Yang ZY; Zhang T; Cao HM; Wang RX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):456-60. PubMed ID: 23926016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C4280A (rs5705) gene polymorphism of the renin (REN) gene is associated with risk of developing coronary artery disease, but not with restenosis after coronary stenting.
    Fragoso JM; Alvarez-León E; Delgadillo-Rodríguez H; Arellano-González M; López-Pacheco FC; Cruz-Robles D; Peña-Duque MA; Pérez-Méndez O; Martínez-Ríos MA; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Aug; 99(1):128-32. PubMed ID: 26102248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
    Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
    Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.
    On YK; Park HK; Hyon MS; Jeon ES
    Circ J; 2007 Jun; 71(6):868-73. PubMed ID: 17526982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
    Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F;
    JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA].
    Warzée F; Legrand V; Scheen AJ
    Rev Med Liege; 2004 Oct; 59(10):584-90. PubMed ID: 15623079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.
    Qiao Y; Ma C; Nie S; Liu X; Kang J; Lv Q; Du X; Hu R; Zhang Y; Jia C; Liu X; Dong J; Chen F; Zhou Y; Lv S; Huang F; Gu C; Wu X
    Clin Cardiol; 2009 Aug; 32(8):E24-30. PubMed ID: 19455692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
    Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
    J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.
    Zhao Q; Wei H; Liu D; Shi B; Li L; Yan M; Zhang X; Wang F; Ouyang Y
    Oncotarget; 2017 Jan; 8(1):658-663. PubMed ID: 27893421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.
    Kim YG; Park DW; Lee WS; Park GM; Sun BJ; Lee CH; Hwang KW; Cho SW; Kim YR; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Han S; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Am J Cardiol; 2012 Jun; 109(11):1548-57. PubMed ID: 22425329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of diabetes mellitus on long-term outcomes of patients with unprotected left main coronary artery disease treated with either drug-eluting stents or coronary artery bypass grafting.
    Yu X; He J; Luo Y; Yuan F; Song X; Gao Y; Li Q; Huang F; Gu C; Lv S; Chen F
    Int Heart J; 2015; 56(1):43-8. PubMed ID: 25742942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty, and coronary artery bypass graft.
    Ishikawa K; Aoyama Y; Kato K; Tanaka A; Hiramatsu M; Ajioka M; Kamiya H; Tanaka T; Hirayama H
    J Card Surg; 2013 Mar; 28(2):97-101. PubMed ID: 23347085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
    Wood A; Antonopoulos A; Chuaiphichai S; Kyriakou T; Diaz R; Al Hussaini A; Marsh AM; Sian M; Meisuria M; McCann G; Rashbrook VS; Drydale E; Draycott S; Polkinghorne MD; Akoumianakis I; Antoniades C; Watkins H; Channon KM; Adlam D; Douglas G
    Cardiovasc Res; 2023 Mar; 119(2):599-610. PubMed ID: 35653516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.
    Shah SH; Hauser ER; Crosslin D; Wang L; Haynes C; Connelly J; Nelson S; Johnson J; Gadson S; Nelson CL; Seo D; Gregory S; Kraus WE; Granger CB; Goldschmidt-Clermont P; Newby LK
    Atherosclerosis; 2008 Nov; 201(1):148-54. PubMed ID: 18374923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of very long-term clinical and angiographic outcomes of bare metal stent implants between patients with and without type 2 diabetes.
    Lu CH; Tsai ML; Chen CC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Chen DY; Yang CH; Hsieh IC
    Prim Care Diabetes; 2017 Oct; 11(5):445-452. PubMed ID: 28576662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.